Labshake search
Citations for Stemcell Technologies :
5901 - 5950 of 8825 citations since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2021Quote: ... in mTeSR™-Plus medium (STEMCELL Technologies, 100-0276), and passaged when 90% confluent using ReLeSR™ enzyme-free selective passaging reagent (STEMCELL Technologies ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 ng/mL human recombinant Leukemia Inhibitory Factor (LIF, STEMCELL Technologies, 78055.1) and 10 ng/mL human recombinant Epidermal Growth Factor (EGF ...
-
bioRxiv - Bioengineering 2021Quote: ... and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2, STEMCELL Technologies, 78003.1) in RPMI 1640 for 2 days ...
-
bioRxiv - Bioengineering 2021Quote: ... and 10 ng/mL human recombinant Epidermal Growth Factor (EGF, STEMCELL Technologies, 78006.1), and passaged using TrypLE™ Express Enzyme.
-
bioRxiv - Bioengineering 2021Quote: ... we first patterned the hiPSCs with a mesenchymal protocol as previously described.(Lam, et al., 2014) Cells were treated with 5 µM CHIR99021 (STEMCELL Technologies, 72052) in Roswell Park Memorial Institute Medium 1640 (RPMI 1640 ...
-
bioRxiv - Bioengineering 2021Quote: Testicular biopsies were transported to the lab on ice in Hypothermosol® FRS (STEMCELL Technologies, 07935). They were rinsed three times with Hank’s Balanced Salt Solution (HBSS ...
-
bioRxiv - Bioengineering 2021Quote: ... and 25 ng/mL BMP4 with 50 ng/mL human recombinant Vascular Endothelial Growth Factor 165 (VEGF-165, STEMCELL Technologies, 78073) for 2 days ...
-
bioRxiv - Bioengineering 2021Quote: ... and then 1 µM all-trans retinoic acid (RA, STEMCELL Technologies, 72262) and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2 ...
-
bioRxiv - Bioengineering 2021Quote: ... in AggreWell™ EB Formation Medium (STEMCELL Technologies, 05893), supplemented with 50 ng/mL FGF2 and 30 ng/mL animal-free recombinant human Bone Morphogenic Protein 4 (BMP4 ...
-
bioRxiv - Bioengineering 2021Quote: ... the EasySep™ Human PE Positive Selection Kit II (STEMCELL Technologies, 17664), and EasySep™ Magnet (STEMCELL Technologies ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 ng/mL human recombinant Leukemia Inhibitory Factor (LIF, STEMCELL Technologies, 78055.1) and 10 ng/mL human recombinant Epidermal Growth Factor (EGF ...
-
bioRxiv - Bioengineering 2021Quote: ... 0.2 μM Smoothened Agonist (SAG, STEMCELL Technologies, 73412), 5 μM 22R-hydroxycholesterol (22R-OHC ...
-
bioRxiv - Bioengineering 2021Quote: ... and 40 ng/mL animal component-free human recombinant Activin A (STEMCELL Technologies, 78132) for 12 days with media changes every other day ...
-
bioRxiv - Bioengineering 2021Quote: ... and 10 ng/mL human recombinant Epidermal Growth Factor (EGF, STEMCELL Technologies, 78006.1), and passaged using TrypLE™ Express Enzyme.
-
bioRxiv - Bioengineering 2021Quote: ... hiPSCs were made into embryoid bodies using AggreWell™800 microwells (STEMCELL Technologies, 34811) in AggreWell™ EB Formation Medium (STEMCELL Technologies ...
-
bioRxiv - Bioengineering 2021Quote: ... and passaged when 90% confluent using ReLeSR™ selective passaging reagent (STEMCELL Technologies, 05872) to maintain purity.
-
bioRxiv - Bioengineering 2021Quote: ... in mTeSR™-Plus medium (STEMCELL Technologies, 100-0276), at 37°C and 5% CO2 ...
-
bioRxiv - Bioengineering 2021Quote: ... Cells were cultured throughout on Matrigel substrates in Dulbecco’s Modified Eagle Medium/Nutrient Mixture F-12 with 15mM HEPES (DMEM/F12, STEMCELL Technologies, 36254) 1X Insulin Transferrin Selenium Liquid Media Supplement (ITS ...
-
bioRxiv - Bioengineering 2021Quote: hiPSC-derived endothelial cells (hECs) were differentiated as previously described.[85] hiPSCs were subjected to 5 μM CHIR99021 in STEMdiff APEL 2 Medium (STEMCELL Technologies, 05270) for 24 hours ...
-
bioRxiv - Bioengineering 2021Quote: ... and EasySep™ Magnet (STEMCELL Technologies, 18000). The purified cells were then expanded on PLL-coated plates in Endothelial Cell Growth Medium (Promocell ...
-
bioRxiv - Bioengineering 2021Quote: ... 20 ng/mL animal component-free human recombinant Glial Cell Derived Neurotrophic Factor (GDNF, STEMCELL Technologies, 78139), 0.2% Chemically Defined Lipid Concentrate (Thermofisher ...
-
bioRxiv - Bioengineering 2021Quote: ... Cells were passaged onto CellAdhere™ Laminin-521 coated plates (STEMCELL Technologies, 77004) using TrypLE™ Express Enzyme (Gibco) ...
-
bioRxiv - Bioengineering 2021Quote: ... The following day the organoids were transferred to Ultra-Low Adherent Plates for Suspension Culture (STEMCELL Technologies, 38071), at 1 Aggrewell™800 well per well (of a 6-well plate) ...
-
bioRxiv - Bioengineering 2021Quote: ... we first directed the hiPSCs towards an intermediate mesenchymal fate using a previously described protocol,[84] wherein cells are treated with 5 µM CHIR99021 (STEMCELL Technologies, 72052) in Roswell Park Memorial Institute Medium 1640 (RPMI 1640 ...
-
bioRxiv - Bioengineering 2021Quote: ... and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2, STEMCELL Technologies, 78003.1) for 2 days ...
-
bioRxiv - Bioengineering 2021Quote: ... and EasySep™ Magnet (STEMCELL Technologies, 18000).
-
bioRxiv - Bioengineering 2021Quote: ... 10 ng/mL human recombinant Leukemia Inhibitory Factor (LIF, STEMCELL Technologies, 78055.1), and 10 ng/mL GDNF ...
-
bioRxiv - Bioengineering 2021Quote: ... chemically defined CryoStor™ CS10 (STEMCELL Technologies, 07930), placed in a Mr ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2, STEMCELL Technologies, 78003.1), 20 ng/mL animal component-free human recombinant Glial Cell Derived Neurotrophic Factor (GDNF ...
-
bioRxiv - Bioengineering 2021Quote: ... in mTeSR™-Plus medium (STEMCELL Technologies, 100-0276), at 37°C and 5%CO2 ...
-
bioRxiv - Bioengineering 2021Quote: ... 20 ng/mL animal component-free human recombinant Glial Cell Derived Neurotrophic Factor (GDNF, STEMCELL Technologies, 78139), 0.2% Chemically Defined Lipid Concentrate (Thermofisher ...
-
bioRxiv - Bioengineering 2021Quote: ... 20 ng/mL human recombinant Epidermal Growth Factor (EGF, STEMCELL Technologies, 78006.1), 10 ng/mL human recombinant Leukemia Inhibitory Factor (LIF ...
-
bioRxiv - Bioengineering 2021Quote: ... the EasySep™ Human PE Positive Selection Kit II (STEMCELL Technologies, 17664), and EasySep™ Magnet (STEMCELL Technologies ...
-
bioRxiv - Bioengineering 2021Quote: ... and passaged when 90% confluent using ReLeSR™ enzyme-free selective passaging reagent (STEMCELL Technologies, 05872) to maintain purity.
-
bioRxiv - Bioengineering 2021Quote: Primary testicular cells were isolated from human testicular biopsies as previously described.[41] Testicular biopsies were transported to the lab on ice in Hypothermosol® FRS (STEMCELL Technologies, 07935) and processed within 1-2 hours ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 20% BIT (Stem Cell Technologies), 50 U/mL Penicillin ...
-
bioRxiv - Bioengineering 2021Quote: ... and NKX2.5EGFP/+ hPSCs31 were maintained on Matrigel (Corning)-coated surfaces in mTeSR1 (STEMCELL Technologies) as previously described44 ...
-
bioRxiv - Bioengineering 2021Quote: ... CD4+ T cells were isolated from PBMCs by negative magnetic selection using EasySep Human CD4 T cell Isolation Kit (StemCell Technologies). Isolated T cells were then plated in ImmunoCult-XF T Cell Expansion Medium (StemCell Technologies ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 10 ng μL-1 recombinant human IL-2 (StemCell Technologies) and activated with the ImmunoCult Human CD3/CD28 T Cell Activator (StemCell Technologies) ...
-
bioRxiv - Bioengineering 2021Quote: ... Peripheral blood mononuclear cells (PBMCs) were isolated using Lymphoprep density gradient centrifugation (StemCell Technologies). CD8+ T cells were isolated from PBMCs by positive magnetic selection using EasySep Human CD8 Positive Selection Kit (StemCell Technologies) ...
-
bioRxiv - Bioengineering 2021Quote: ... CD8+ T cells were isolated from PBMCs by positive magnetic selection using EasySep Human CD8 Positive Selection Kit (StemCell Technologies). CD4+ T cells were isolated from PBMCs by negative magnetic selection using EasySep Human CD4 T cell Isolation Kit (StemCell Technologies) ...
-
bioRxiv - Bioengineering 2021Quote: ... Isolated T cells were then plated in ImmunoCult-XF T Cell Expansion Medium (StemCell Technologies) supplemented with 10 ng μL-1 recombinant human IL-2 (StemCell Technologies ...
-
bioRxiv - Bioengineering 2021Quote: ... and activated with the ImmunoCult Human CD3/CD28 T Cell Activator (StemCell Technologies). T cells were cultured at 37°C ...
-
bioRxiv - Bioengineering 2021Quote: ... we first dissociated hESCs into single cells and re-aggregated them in Aggrewell 800 well plates (STEMcell Technologies) at a density of 3,000,000 cells per well with 2mL of Aggrewell Medium (STEMcell Technologies ...
-
bioRxiv - Bioengineering 2021Quote: ... at a density of 3,000,000 cells per well with 2mL of Aggrewell Medium (STEMcell Technologies) supplemented with Rho Kinase Inhibitor (Y-27632 ...
-
bioRxiv - Neuroscience 2021Quote: ... Cells were spun down and resuspended in BrainPhys (StemCell Technologies, 05790) supplemented with B27 (Thermo Fisher ...
-
bioRxiv - Bioengineering 2021Quote: ... Purified pDCs were isolated via the EasySep™ Human Plasmacytoid DC Enrichment Kit (STEMCELL Technologies; Vancouver, Canada). Soluble or CQ-loaded nanocarriers at 3.91 μM total drug were cultured with 100,000 pDCs in RPMI 1640 with GlutaMAX plus 10% FBS ...
-
bioRxiv - Bioengineering 2021Quote: A testicular biopsy was transported to the lab on ice in Hypothermosol® FRS (STEMCELL Technologies, 07935), and digested as previously described.(16 ...
-
bioRxiv - Bioengineering 2021Quote: ... Prints were cultured in Ultra-Low Adherent Plates for Suspension Culture (STEMCELL Technologies, 38071) for 12 days in SSC expansion media with the following additions ...
-
bioRxiv - Bioengineering 2021Quote: ... and 10 μM all-trans retinoic acid (RA, STEMCELL Technologies, 72262), and the removal of Glial Cell Derived Neurotrophic Factor (GDNF).